| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Pyxis Oncology, Inc.
13D/A
PYXS · 747324101
|
11.2% |
4/2/2025
Event 3/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.